R0 resection combined with targeted therapy may be necessary for controlling recurrent metastatic retroperitoneal dedifferentiated liposarcoma.
The case demonstrated that the postoperative recurrence of widespread RPLPS required R0 resection to cure the disease, considering targeted therapy for advanced RPLPS control.
Liao et al. (2023) studied this question.